A phase Ib study of oral panobinostat (LBH589) administered with 5-azacitidine (5-Aza) in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML).
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: O. G. Ottmann, P. Fenaux, M. Lübbert, D. J. DeAngelo, G. Garcia-Manero, K. N. Bhalla, M. A. Sekeres, F. Lüdicke, H. J. Weber, I. J. Winiger
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2270191540